Tag Archives: Perrigo

November, 2015

• 13 November

  Perrigo Shareholders Reject Mylan Hostile Takeover Bid

  

  DUBLIN, Nov. 13, 2015 /PRNewswire/ — Perrigo Company plc (“Perrigo,” “the Company”) (NYSE: PRGO; TASE) today responded to the news that holders of a majority of its shares rejected Mylan’s hostile tender offer, thereby expressing confidence in Perrigo’s long-term strategy, vision, and management plans for the future.  Shareholders holding over 60% …

  Share

  • Facebook
  • Twitter
  • LinkedIn

April, 2015

• 27 April

  Mylan Stays Committed to Acquiring Perrigo, Rejecting Teva’s $40 Billion Takeover Bid

  

  Today, Mylan NV announced that its board of directors unanimously rejected Teva Pharmaceutical Industries’ $40.1 billion takeover bid. The company stated that its board determined that the offer from Teva “grossly undervalues Mylan.” On April 21, 2015, Teva announced the unsolicited acquisition bid of Mylan NV, offering the company a …

  Share

  • Facebook
  • Twitter
  • LinkedIn
• 23 April

  Perrigo Rejects Mylan’s $29 Billion Takeover Bid

  

  Generic drugmaker Perrigo Company announced that its Board of Directors unanimously rejected Mylan’s unsolicited $29 billion takeover bid, claiming that the proposal substantially undervalues the company. Earlier this month, Mylan offered $205 per share in cash and stock for the Dublin-based company. Perrigo said Tuesday that the previous offer undervalues …

  Share

  • Facebook
  • Twitter
  • LinkedIn
• 21 April

  Teva Confirms Speculations with Unsolicited Offer to Acquire Mylan for $40.1 Billion

  

  Teva has confirmed speculations of a possible Mylan takeover bid, announcing a proposal to purchase all of the outstanding shares of Mylan for about $40.1 billion. Teva, the world’s largest generics drugmaker, made an unsolicited offer to acquire the company in a cash and stock transaction valued at $82 per …

  Share

  • Facebook
  • Twitter
  • LinkedIn